Efficacy of L-Ornithine L-Aspartate and Polyethylene Glycol in Cirrhotic Patients With Overt Hepatic Encephalopathy
HELP Trial: Efficacy of L-Ornithine L-Aspartate and Polyethylene Glycol in Cirrhotic Patients With Overt Hepatic Encephalopathy
Sponsor: Jinnah Postgraduate Medical Centre
A PHASE4 clinical study on Hepatic Encephalopathy Stage 2 and Hepatic Encephalopathy Stage 3, this trial is ongoing. The trial is conducted by Jinnah Postgraduate Medical Centre and has accumulated 5 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Aug 2025 — Present [monthly]
Unknown PHASE4
Status: Not Yet Recruiting → Unknown
-
Sep 2024 — Aug 2025 [monthly]
Not Yet Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting PHASE4
-
Aug 2023 — Jul 2024 [monthly]
Not Yet Recruiting PHASE4
-
Jul 2023 — Aug 2023 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Jinnah Postgraduate Medical Centre
For direct contact, visit the study record on ClinicalTrials.gov .